Match!
Peter H. Bennett
National Institutes of Health
EndocrinologyInsulinPopulationDiabetes mellitusMedicine
310Publications
89H-index
38.5kCitations
What is this?
Publications 270
Newest
#1Guangwei Li (Academy of Medical Sciences, United Kingdom)H-Index: 11
#2Ping Zhang (CDC: Centers for Disease Control and Prevention)H-Index: 38
Last. Peter H. Bennett (NIH: National Institutes of Health)H-Index: 89
view all 3 authors...
Source
#1David M. Nathan (Harvard University)H-Index: 107
#2Peter H. Bennett (NIH: National Institutes of Health)H-Index: 89
Last. Neil H. White (WashU: Washington University in St. Louis)H-Index: 51
view all 12 authors...
The global epidemic of type 2 diabetes has prompted numerous studies and public health efforts to reduce its development. A variety of interventions, including lifestyle modifications and pharmacological agents directed at ameliorating the major risk factors for type 2 diabetes, are of proven efficacy in reducing the development of type 2 diabetes in people with impaired glucose tolerance. While prevention of the hyperglycaemia characteristic of diabetes is arguably an important, clinically rele...
4 CitationsSource
1 CitationsSource
#1Yanyan ChenH-Index: 2
#2Ping ZhangH-Index: 38
Last. Guangwei LiH-Index: 11
view all 8 authors...
Responses to lifestyle interventions in people with impaired glucose tolerance (IGT) may differ during the intervention phase: some progress to diabetes, some regress to normal glucose tolerance (NGT) and some retain IGT. Whether these different responses to intervention influence subsequent outcomes is uncertain. In 1986, 576 persons with IGT in Da Qing, China, were randomized to control or intervention (diet, exercise, diet plus exercise) groups for a six-year lifestyle intervention. In 1992, ...
Source
#1Yali AnH-Index: 3
#2Ping ZhangH-Index: 38
Last. Guangwei LiH-Index: 11
view all 9 authors...
Source
#1Qiuhong Gong (Academy of Medical Sciences, United Kingdom)H-Index: 1
#2Ping Zhang (CDC: Centers for Disease Control and Prevention)H-Index: 38
Last. Gojka RoglicH-Index: 22
view all 51 authors...
Summary Background Lifestyle interventions can delay the onset of type 2 diabetes in people with impaired glucose tolerance, but whether this leads subsequently to fewer complications or to increased longevity is uncertain. We aimed to assess the long-term effects of lifestyle interventions in people with impaired glucose tolerance on the incidence of diabetes, its complications, and mortality. Methods The original study was a cluster randomised trial, started in 1986, in which 33 clinics in Da ...
10 CitationsSource
#1Wen-Chi Hsueh (NIH: National Institutes of Health)H-Index: 29
#2Peter H. Bennett (NIH: National Institutes of Health)H-Index: 89
Last. Robert L. Hanson (NIH: National Institutes of Health)H-Index: 72
view all 11 authors...
1 CitationsSource
#1Meda E. PavkovH-Index: 20
#2Annika HoyerH-Index: 9
Last. Peter H. BennettH-Index: 89
view all 5 authors...
The combination of high diabetes prevalence, declining mortality trends and high chronic kidney disease (CKD) prevalence has raised concerns about the future burden of CKD in the American Indian population. We modeled the future prevalence of diabetes and CKD in a Southwestern American Indian population well-characterized for type 2 diabetes using data from research examinations conducted on 4,476 participants between 1965 and 2007. Diabetes was assessed by 2-hour glucose tolerance testing, CKD ...
Source
#1Qiuhong GongH-Index: 2
#2Ping ZhangH-Index: 38
Last. Guangwei LiH-Index: 11
view all 13 authors...
Lifestyle interventions can prevent or delay type 2 diabetes (T2DM) but their long-term effect on cardiovascular disease (CVD) remains unclear. We assessed the effect of lifestyle interventions on the incidence of CVD events among Chinese adults with impaired glucose tolerance (IGT) who participated in the Da Qing Diabetes Prevention Study (DQDPS) and who were followed for up to 30 years after randomization. DQDPS was a 6-year clinical trial conducted in Da Qing, China from 1986 to 1992 in which...
Source
#1Xiaoxia Shen (Academy of Medical Sciences, United Kingdom)H-Index: 1
#2Ping Zhang (CDC: Centers for Disease Control and Prevention)H-Index: 38
Last. Guangwei Li (Academy of Medical Sciences, United Kingdom)H-Index: 11
view all 14 authors...
Background and aimWe sought to determine the effect of regression to normal glucose tolerance (NGT) or progression to diabetes in early years of impaired glucose tolerance (IGT) on subsequent risk ...
Source
12345678910